Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation

Background Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to androgen-deprivation therapy. Few case presentations describe this association; the novelty lies in th...

Full description

Autores:
Morales, Ximena
Garnica, Diego
Isaza, Daniel
Isaza, Nicolas
Durán-Torres, Felipe
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5918
Acceso en línea:
http://hdl.handle.net/20.500.12495/5918
https://doi.org/10.1186/s12872-021-01945-3
Palabra clave:
Prostatic neoplasms
Abiraterone acetate
Leuprolide
Androgen-deprivation
Ventricular tachycardia
Hypokalemia
Case presentation
Rights
openAccess
License
Atribución 4.0 Internacional
id UNBOSQUE2_763146d71fd1007924b06ca4cacc7dd5
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/5918
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
dc.title.translated.spa.fl_str_mv Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
title Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
spellingShingle Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
Prostatic neoplasms
Abiraterone acetate
Leuprolide
Androgen-deprivation
Ventricular tachycardia
Hypokalemia
Case presentation
title_short Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
title_full Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
title_fullStr Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
title_full_unstemmed Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
title_sort Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
dc.creator.fl_str_mv Morales, Ximena
Garnica, Diego
Isaza, Daniel
Isaza, Nicolas
Durán-Torres, Felipe
dc.contributor.author.none.fl_str_mv Morales, Ximena
Garnica, Diego
Isaza, Daniel
Isaza, Nicolas
Durán-Torres, Felipe
dc.subject.keywords.spa.fl_str_mv Prostatic neoplasms
Abiraterone acetate
Leuprolide
Androgen-deprivation
Ventricular tachycardia
Hypokalemia
Case presentation
topic Prostatic neoplasms
Abiraterone acetate
Leuprolide
Androgen-deprivation
Ventricular tachycardia
Hypokalemia
Case presentation
description Background Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to androgen-deprivation therapy. Few case presentations describe this association; the novelty lies in the potentially lethal cardiovascular events among cancer patients receiving hormonal therapy. Case presentation A 70-year-old male presented with recurrent syncope without prodrome. ECG revealed frequent ventricular ectopy, non-sustained episodes of TdP, and severe hypomagnesemia and hypokalemia. During potassium and magnesium infusion for repletion, the patient underwent temporary transvenous atrial pacing. As part of the work-up, coronary angiography revealed a mild coronary artery disease, and transthoracic echocardiogram showed a moderately depressed ejection fraction. After electrolyte disturbances were corrected, the QT interval normalized, and transvenous pacing was no longer necessary. Abiraterone was discontinued during the admission, and the patient returned to baseline. Conclusions Cancer treatment is complex and requires a multidisciplinary approach. We presented a case of non-sustained TdP associated with androgen-deprivation therapy in an elderly patient with mild coronary artery disease and moderately reduced ejection fraction. Close follow-up and increased awareness are required in patients with hormonal treatment, especially in the setting of other cardiovascular risk factors.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-07-02T14:54:32Z
dc.date.available.none.fl_str_mv 2021-07-02T14:54:32Z
dc.date.issued.none.fl_str_mv 2021-03-12
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1471-2261
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/5918
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1186/s12872-021-01945-3
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv repourl:https://repositorio.unbosque.edu.co
identifier_str_mv 1471-2261
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
repourl:https://repositorio.unbosque.edu.co
url http://hdl.handle.net/20.500.12495/5918
https://doi.org/10.1186/s12872-021-01945-3
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv BMC Cardiovascular Disorders, 1471-2261, Vol. 21, No. 01, 2021, art. 136
dc.relation.uri.none.fl_str_mv https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-01945-3
dc.rights.*.fl_str_mv Atribución 4.0 Internacional
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
rights_invalid_str_mv Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
Acceso abierto
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer Nature
BioMed Central
dc.publisher.journal.spa.fl_str_mv BMC Cardiovascular Disorders
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/9d51a696-8126-4cc6-83ef-fdf6f58f975d/download
https://repositorio.unbosque.edu.co/bitstreams/9adc8ba3-4de7-4e80-a4ab-75dfbc20666c/download
https://repositorio.unbosque.edu.co/bitstreams/de571ec7-76e1-4ade-aa43-5151fa4ee021/download
https://repositorio.unbosque.edu.co/bitstreams/2b95ef9b-3379-4c87-81e0-fba81d2e19e5/download
https://repositorio.unbosque.edu.co/bitstreams/25d01644-d571-43ba-a897-7d743d20175f/download
bitstream.checksum.fl_str_mv 8e26458da1dfc4f2bf1c54be0a1f3cb1
8a4605be74aa9ea9d79846c1fba20a33
77fcd51d347fa5314c1d80dc44410575
0175ea4a2d4caec4bbcc37e300941108
506c7eef3cf656c4f81f29e8e798b25d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100848469344256
spelling Morales, XimenaGarnica, DiegoIsaza, DanielIsaza, NicolasDurán-Torres, Felipe2021-07-02T14:54:32Z2021-07-02T14:54:32Z2021-03-121471-2261http://hdl.handle.net/20.500.12495/5918https://doi.org/10.1186/s12872-021-01945-3instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengSpringer NatureBioMed CentralBMC Cardiovascular DisordersBMC Cardiovascular Disorders, 1471-2261, Vol. 21, No. 01, 2021, art. 136https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-01945-3Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abiertoSyncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentationSyncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentationArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Prostatic neoplasmsAbiraterone acetateLeuprolideAndrogen-deprivationVentricular tachycardiaHypokalemiaCase presentationBackground Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to androgen-deprivation therapy. Few case presentations describe this association; the novelty lies in the potentially lethal cardiovascular events among cancer patients receiving hormonal therapy. Case presentation A 70-year-old male presented with recurrent syncope without prodrome. ECG revealed frequent ventricular ectopy, non-sustained episodes of TdP, and severe hypomagnesemia and hypokalemia. During potassium and magnesium infusion for repletion, the patient underwent temporary transvenous atrial pacing. As part of the work-up, coronary angiography revealed a mild coronary artery disease, and transthoracic echocardiogram showed a moderately depressed ejection fraction. After electrolyte disturbances were corrected, the QT interval normalized, and transvenous pacing was no longer necessary. Abiraterone was discontinued during the admission, and the patient returned to baseline. Conclusions Cancer treatment is complex and requires a multidisciplinary approach. We presented a case of non-sustained TdP associated with androgen-deprivation therapy in an elderly patient with mild coronary artery disease and moderately reduced ejection fraction. Close follow-up and increased awareness are required in patients with hormonal treatment, especially in the setting of other cardiovascular risk factors.ORIGINALMorales_Ximena_2021.pdfMorales_Ximena_2021.pdfapplication/pdf1301692https://repositorio.unbosque.edu.co/bitstreams/9d51a696-8126-4cc6-83ef-fdf6f58f975d/download8e26458da1dfc4f2bf1c54be0a1f3cb1MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/9adc8ba3-4de7-4e80-a4ab-75dfbc20666c/download8a4605be74aa9ea9d79846c1fba20a33MD53THUMBNAILMorales_Ximena_2021.pdf.jpgMorales_Ximena_2021.pdf.jpgIM Thumbnailimage/jpeg10192https://repositorio.unbosque.edu.co/bitstreams/de571ec7-76e1-4ade-aa43-5151fa4ee021/download77fcd51d347fa5314c1d80dc44410575MD54CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8908https://repositorio.unbosque.edu.co/bitstreams/2b95ef9b-3379-4c87-81e0-fba81d2e19e5/download0175ea4a2d4caec4bbcc37e300941108MD52TEXTMorales_Ximena_2021.pdf.txtMorales_Ximena_2021.pdf.txtExtracted texttext/plain23137https://repositorio.unbosque.edu.co/bitstreams/25d01644-d571-43ba-a897-7d743d20175f/download506c7eef3cf656c4f81f29e8e798b25dMD5520.500.12495/5918oai:repositorio.unbosque.edu.co:20.500.12495/59182024-02-07 14:05:10.061http://creativecommons.org/licenses/by/4.0/Atribución 4.0 Internacionalopen.accesshttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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